AMLX financials
Amylyx Pharmaceuticals (AMLX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AMLX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$525.00K | -$153.29M | -$144.74M | -1.53 |
| 2024 | $87.37M | $45.22M | -$314.73M | -$301.74M | -4.43 |
| 2023 | $380.79M | $355.35M | $38.80M | $49.27M | 0.70 |
| 2022 | $22.23M | $19.24M | -$201.34M | -$198.38M | -2.98 |
| 2021 | $0.00 | $0.00 | -$82.69M | -$87.93M | -1.52 |
| 2020 | $650.00K | -$23.94M | -$39.01M | -$42.28M | -0.79 |